Solid Biosciences's total assets for Q4 2025 were $232.54M, a decrease of -15.10% from the previous quarter. SLDB total liabilities were $52.53M for the fiscal quarter, a -6.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.